UP!

VCYT $22.74

VCYT target price
22.74
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2022 2022-07-27 Future report Set alerts
Q1 2022 2022-05-03 -0.20 -0.20
Q4 2021 2022-02-28 -0.15 -0.15
Q3 2021 2021-11-09 -0.20 -0.20
Q2 2021 2021-07-29 -0.13 -0.13
Q1 2021 2021-05-10 -0.66 -0.66
Q4 2020 2021-02-17 -0.14 -0.14
Q3 2020 2020-11-02 0.00 0.00
Q2 2020 2020-07-30 -0.22 -0.22
Q1 2020 2020-05-06 -0.24 -0.24

Ratings

2016-06-29 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-06-23 Reiterated Rating Leerink Swann Buy
2016-06-21 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-06-13 Reiterated Rating Cantor Fitzgerald Buy
2016-06-13 Reiterated Rating BTIG Research Buy $10.00
2016-05-06 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-03-13 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-03-11 Reiterated Rating Leerink Swann Buy $11.00 to $8.00
2016-02-19 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-01-22 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-12-17 Initiated Coverage Cantor Fitzgerald Buy $13.00
2015-12-15 Reiterated Rating BTIG Research Buy $11.00
2015-11-19 Reiterated Rating Stephens Buy
2015-11-07 Reiterated Rating Leerink Swann Buy
2015-11-06 Reiterated Rating BTIG Research Buy $11.00
2015-11-06 Lower Price Target Leerink Swann Outperform $13.00 to $11.00
2015-10-18 Reiterated Rating BTIG Research Buy $11.00
2015-10-14 Lower Price Target Cowen and Company Outperform $12.00 to $8.00
2015-10-02 Reiterated Rating BTIG Research Buy $11.00
2015-08-14 Reiterated Rating Piper Jaffray Overweight $13.00 to $12.00
2015-08-14 Reiterated Rating BTIG Research Buy $13.00
2015-08-14 Reiterated Rating Piper Jaffray Cos. Overweight $13.00 to $12.00
2015-06-25 Reiterated Rating BTIG Research Buy $13.00
2015-06-11 Boost Price Target Leerink Swann Outperform $11.00 to $13.00
2015-05-15 Reiterated Rating BTIG Research Buy $11.00
2015-04-06 Initiated Coverage BTIG Research Buy $11.00
2015-03-22 Reiterated Rating William Blair Outperform
2015-03-20 Reiterated Rating Morgan Stanley Equal Weight $9.00
2015-03-20 Lower Price Target Leerink Swann $11.00
2014-11-14 Downgrade Janney Montgomery Scott Buy to Neutral $11.00
2014-11-10 Initiated Coverage Morgan Stanley Equal Weight
2014-10-07 Initiated Coverage Stephens Overweight $14.00
2014-08-14 Lower Price Target Leerink Swann Outperform $23.00 to $20.00
2014-06-26 Initiated Coverage Janney Montgomery Scott Buy to Buy $25.00
2014-06-19 Initiated Coverage Piper Jaffray Overweight $21.00
2014-03-19 Boost Price Target Cowen and Company Outperform $17.00 to $22.00
2014-03-19 Boost Price Target Leerink Swann $21.00 to $23.00
2013-11-26 Initiated Coverage William Blair Outperform
2013-11-26 Initiated Coverage Cowen and Company Outperform $16.00
2013-11-26 Initiated Coverage Leerink Swann Outperform $17.00
2013-11-26 Initiated Coverage Morgan Stanley Overweight $16.00
2016-06-29 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-06-23 Reiterated Rating Leerink Swann Buy
2016-06-21 Reiterated Rating Cantor Fitzgerald Buy $13.00
2016-06-13 Reiterated Rating Cantor Fitzgerald Buy
2016-06-13 Reiterated Rating BTIG Research Buy $10.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
TPG Group Holdings (SBS) Advisors, Inc. 16.53%  (3551929) AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH /
BYERS BROOK H 16.53%  (3551929) CDNA / FMI / PACB / VCYT /
KLEINER PERKINS CAUFIELD & BYERS XII, LLC 13.04%  (2801929) VCYT /
Domain Partners VIII, L.P. 12.86%  (2763294) ACHN / DRNA / DRTX / OCRX / OTIC / VCYT /
JONES EVAN/ FA 1.30%  (279653) CASM / FLDM / FMI / VCYT /
Anderson Bonnie H President and CEO 0.24%  (52541) VCYT /
Hall Christopher M Chief Commercial Officer 0.15%  (32455) VCYT /
Kennedy Keith Chief Financial Officer 0.13%  (28114) MCGC / VCYT /
DP VIII Associates, L.P. 0.11%  (22730) DRNA / DRTX / OCRX / OTIC / VCYT /
DOVEY BRIAN H 0.11%  (22730) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / OTIC / RGDO / TNDM / VCYT / ZGNX /
BLAIR JAMES C 0.11%  (22730) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
Halak Brian K 0.11%  (22730) ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX /
SCHOEMAKER KATHLEEN K 0.11%  (22730) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
VITULLO NICOLE 0.11%  (22730) ACHN / AKAO / CADX / CLVS / CPXX / DRNA / DRTX / ESPR / EVOK / MRNS / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
Versant Ventures III, LLC 0.10%  (21232) FLXN / VCYT /
ATWOOD BRIAN G 0.10%  (21232) CADX / CLVS / FPRX / IMDZ / PZRX / VCYT /
COLELLA SAMUEL D 0.10%  (21232) ALXA / FLDM / FLXN / GHDX / VCYT /
EASTHAM KARIN 0.06%  (13227) GERN / ILMN / VCYT /
Brooks Julie EVP,General Counsel,Secretary 0.02%  (4162) VCYT /